Clinical pearl of the day in pharmacies: liver cancer


[ad_1]

Risk factors for liver cancer include chronic infection with hepatitis B or hepatitis C virus, cirrhosis, diabetes, and non-alcoholic fatty liver disease.

Clinical gem of the day: liver cancer

Liver cancer begins in the cells of the liver.

Overview:

  • The most common type of liver cancer is hepatocellular carcinoma, which starts in the main type of liver cell (hepatocyte).
  • Some of the symptoms include weight loss, loss of appetite, upper abdominal pain, vomiting, general weakness, abdominal swelling, white and chalky stools.
  • Risk factors include chronic infection with hepatitis B or hepatitis C virus, cirrhosis, inherited liver disease, diabetes, non-alcoholic fatty liver disease, and alcohol consumption.
  • Diagnostic includes a blood test, imaging tests, and taking a sample of the liver for a biopsy.
  • Processing includes surgery, targeted drug therapy, immunotherapy, chemotherapy and supportive care.
  • Some of the chemotherapy drugs include gemcitabine (Gemzar), oxaliplatin (Eloxatin), cisplatin, doxorubicin (pegylated liposomal doxorubicin), 5-fluorouracil (5-FU), capecitabine (Xeloda), and mitoxantrone (Novantrone) ).
  • Sources:

Liver cancer – Diagnosis and treatment – Mayo Clinic

Chemotherapy for liver cancer

[ad_2]

Comments are closed.